Intersect ENT Reports Second Quarter 2016 Results

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2016.

•Second quarter 2016 revenue was $19.3 million, representing a 27% increase over the second quarter 2015.

Back to news